US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

110.53

-0.6062-0.55%

Post-market: 110.50-0.0338-0.03%19:30 EDT

Volume:97.95K

Turnover:10.83M

Market Cap:1.00B

PE:89.56

High:111.04

Open:110.96

Low:110.01

Close:111.14

52wk High:118.00

52wk Low:85.91

Shares:9.09M

Float Shares:9.09M

Volume Ratio:0.41

T/O Rate:1.08%

Dividend:2.18

Dividend Rate:1.97%

EPS(TTM):1.23

EPS(LYR):0.7765

ROE:--

ROA:--

PB:--

PE(LYR):142.35

Loading ...

Overview Company News Filings

Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

Yen advances to six-month high, chip stocks rise

Nicholas Reynolds / Bloomberg

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

Novo Nordisk (NVO) Hit by Another Heart Drug Setback

European Equities Remain Flat as Energy Gains Offset by Pharma Slump

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

Novartis AG Falls Monday, Underperforms Market

Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market

Citi says Novartis news increases likelihood Crispr prioritizes next-gen CTX321

Citi sees limited immediate downside for Ionis after pelacarsen failure

Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial

BofA sees low single-digit percentage downside for Novartis on pelacarsen miss

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

Novartis Heart-Trial Failure Could be Mitigated by Investor Caution

Novartis India - Deal Valued at 12.50 Bln Rupees

THOMSON REUTERS

Novartis Shares to Take Hit from Cholesterol Trial Failure

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/PPH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","market":"US","secType":"STK","nameCN":"VanEck Pharmaceutical ETF","latestPrice":110.5338,"timestamp":1789502400000,"preClose":111.14,"halted":0,"volume":97954,"hourTrading":{"tag":"盘后","latestPrice":110.5,"preClose":110.5338,"latestTime":"19:30 EDT","volume":4875,"amount":539044.9345,"timestamp":1789515006750,"change":-0.0338,"changeRate":-0.000306,"amplitude":0.000724},"delay":0,"changeRate":-0.005454381860716224,"floatShares":9088138,"shares":9088138,"eps":1.234146,"marketStatus":"Closed","change":-0.6062,"latestTime":"09-15 16:00:00 EDT","open":110.96,"high":111.04,"low":110.01,"amount":10830806.10482,"amplitude":0.009268,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.234146,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":111.14,"sharesOutstanding":11938138,"nav":111.14825,"aum":1004573246.11,"dividendRate":0.019703,"bidAskSpread":0.000341,"preHourTrading":{"tag":"盘前","latestPrice":110.97,"preClose":111.14,"latestTime":"09:29 EDT","volume":1205,"amount":133721.50823,"timestamp":1789478999999,"change":-0.17,"changeRate":-0.00153,"amplitude":0.004769},"postHourTrading":{"tag":"盘后","latestPrice":110.5,"preClose":110.5338,"latestTime":"19:30 EDT","volume":4875,"amount":539044.9345,"timestamp":1789515006750,"change":-0.0338,"changeRate":-0.000306,"amplitude":0.000724},"volumeRatio":0.413678,"impliedVol":0.2334,"impliedVolPercentile":0.8685},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","floatShares":9088138,"roa":"--","roe":"--","lyrEps":0.776475,"volumeRatio":0.413678,"shares":9088138,"dividePrice":2.1779,"high":111.04,"amplitude":0.009268,"preClose":111.14,"low":110.01,"week52Low":85.9086,"pbRate":"--","week52High":118,"institutionHeld":0,"latestPrice":110.5338,"eps":1.234146,"divideRate":0.019703,"volume":97954,"delay":0,"ttmEps":1.234146,"open":110.96,"prevYearClose":103.17,"prevWeekClose":109.44,"prevMonthClose":113.08,"prevQuarterClose":109.35,"fiveDayClose":110.43,"twentyDayClose":111.08,"sixtyDayClose":102.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPH\",params:#limit:5,,,undefined,":[{"date":"2026-07-01","symbol":"PPH","amount":0.6248,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-07"},{"date":"2026-04-01","symbol":"PPH","amount":0.8441,"announcedDate":"2026-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-01","defaultRemindTime":1775050200000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-07","payableDate":"2026-04-01","currency":"USD","dateTimestamp":1775016000000,"payDate":"2026-04-07"},{"date":"2025-12-29","symbol":"PPH","amount":0.3106,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-31"},{"date":"2025-10-01","symbol":"PPH","amount":0.3931,"announcedDate":"2025-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-01","defaultRemindTime":1759325400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-06","payableDate":"2025-10-01","currency":"USD","dateTimestamp":1759291200000,"payDate":"2025-10-06"},{"date":"2025-07-01","symbol":"PPH","amount":0.6069,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-01","defaultRemindTime":1751376600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-07-01","currency":"USD","dateTimestamp":1751342400000,"payDate":"2025-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-03","recordDate":"2016-10-05","paymentDate":"2016-10-07","value":0.2148,"currency":"USD"},{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.1449,"currency":"USD"},{"executeDate":"2017-04-03","recordDate":"2017-04-05","paymentDate":"2017-04-07","value":0.4651,"currency":"USD"},{"executeDate":"2017-07-03","recordDate":"2017-07-06","paymentDate":"2017-07-10","value":0.304,"currency":"USD"},{"executeDate":"2017-10-02","recordDate":"2017-10-03","paymentDate":"2017-10-06","value":0.221,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665631001","title":"Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2665631001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665631001?lang=en_us&edition=fundamental","pubTime":"2026-09-08 05:40","pubTimestamp":1788817216,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) has halted two trials testing if ziltivekimab, its experimental heart disease medicine, would help patients with heart failure, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","BK4532","THNR","NVO","BK4007","BK4599","LU0154236417.USD","NVOH","NVOX","OZEM","IE00BZ1G4Q59.USD","PPH","LU1093756325.SGD","BK4585","NVOC","BK4588","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376683","title":"Yen advances to six-month high, chip stocks rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376683","media":"Nicholas Reynolds / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376683?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:14","pubTimestamp":1788804840,"startTime":"0","endTime":"0","summary":"The yen extended Monday's advance to reach the strongest level since February, aided by rising expectations of a Bank of Japan interest-rate increase next week.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["LU1119994496.HKD","LU0690374961.EUR","VFH","LU2237443622.USD","LU0472753341.HKD","BK4567","LU0345774631.USD","BK4207","LU1674673691.USD","GB00B4QBRK32.GBP","LU1496350502.SGD","IE00BMPRXN33.USD","LU2458330243.SGD","LU0251132253.USD","LU1935042215.USD","LU0061474960.USD","ORAC","OZEM","SG9999017495.SGD","LU2357627491.SGD","LU2404859741.USD","LU0889565833.HKD","LU2456880835.USD","LU0964807845.USD","LU0211326839.USD","IE00B5949003.HKD","LU1668664300.SGD","LU1823568750.SGD","IE0034235295.USD","LU0056508442.USD","IE00BHPRN162.USD","LU0342679015.USD","LU1670627923.USD","LU2237443549.SGD","IGV","SG9999000418.SGD","LU1267930490.SGD","BK4527","LU0689472784.USD","LU1064131342.USD","ORCS","LU0868494617.USD","LU2360106780.USD","SG9999014880.SGD","LU1934455863.HKD","BK4528","LU2168564065.EUR","LU0640476718.USD","BK4533","LU2097829019.USD","LU2023250504.SGD","LU0323591593.USD","IE00B3S45H60.SGD","NVO","LU0320765646.SGD","LU1623119135.USD","BK4585","UBEW","LU0265550946.USD","JPO","BK4551","IE00BLSP4239.USD","GB00BDT5M118.USD","LU0965509010.AUD","TDIV","LU0943347566.SGD","NVOX","SG9999018857.SGD","LU1267930730.SGD","LU2505996509.AUD","LU0353189763.USD","LU0980610538.SGD","LU0211327993.USD","LU2210150020.SGD","LU0211328371.USD","LU0949170772.SGD","LU2237957902.USD","LU1894683264.USD","IE00BN8TJ469.HKD","LU0878866978.SGD","SG9999002232.USD","LU2756315664.SGD","LU0444973449.USD","IE00BQXX3F31.USD","LU2237957811.SGD","IE00BYXW3230.USD","LU1363072403.SGD","LU2125154778.USD","LU0006306889.USD","UYG","LU0130102774.USD","LU0476273544.USD","LU2237443382.USD","FTXO","LU0417517546.SGD","LU1145028129.USD","LU0310799852.SGD","LU0081259029.USD","LU1629891620.HKD","SG9999014898.SGD","TPOR","LU1720051017.SGD","LU2237443978.SGD","XLF","LU1551013342.USD","IE00BK4W5M84.HKD","SG9999015978.USD","IXG","LU1116320901.HKD","LU2543165471.USD","LU0256863902.USD","TFNS","LU0256863811.USD","LU1670628061.USD","LU1674673428.USD","UBER","LU0957808578.USD","IE00BYQQ9H92.USD","LU1201861249.SGD","LU1642822529.SGD","LU1435385759.SGD","LU1720051108.HKD","LU2089283258.USD","BK4504","IYF","LU2430703178.SGD","IE00BQXX3C00.GBP","LU2168563687.JPY","IYG","LU1935042991.SGD","BK4535","LU0069063385.USD","LU2213496289.HKD","LU0070302665.USD","LU0211331839.USD","BK4554","LU0068578508.USD","LU2244417387.USD","IE00BDRTCR15.USD","LU2552382058.USD","LU0267386448.USD","LU1032466523.USD","LU2237443895.HKD","IE00BFXG1179.USD","LU0882574139.USD","LU2168564222.USD","LU2552382132.HKD","GB00B4LPDJ14.GBP","LU0859254822.USD","BK4230","BK4599","LU0965509101.SGD","ADBU","LU1691799644.USD","LU2087625088.SGD","IE0009356076.USD","LU0320765059.SGD","LU1861214812.USD","IE00BZ1G4Q59.USD","LU1551013425.SGD","ORCX","LU0345774391.USD","IE0004445239.USD","LU0158827948.USD","LU0211326755.USD","LU2458330169.SGD","LU1914381329.SGD","LU0154236417.USD","BK4516","LU2417539215.USD","IE00B19Z3B42.SGD","LU0444971666.USD","LU0792757196.USD","LU2592432038.USD","LU2317271919.USD","LU0203345920.USD","LU1852331112.SGD","SG9999011175.SGD","LU0985489474.SGD","LU1244550577.SGD","LU0820561818.USD","NVOH","BK4592","LU0648001328.SGD","SG9999014914.USD","LU1974910355.USD","IE00BKVL7J92.USD","LU2430703095.HKD","LU2404859667.USD","SGXZ81514606.USD","LU1989764748.USD","LU0942090050.USD","LU0314106906.USD","PPH","LU2168564149.EUR","LU0965508806.USD","THNR","LU1548497426.USD","LU1815336760.USD","LU0238689110.USD","LU0109392836.USD","LU1489326972.SGD","LU2054465674.USD","LU0661504455.SGD","LU1917777945.USD","FDRV","LU2860962120.EUR","LU0265550359.USD","LU0642271901.SGD","LU1983260115.SGD","LU2250418816.HKD","LU0683600562.USD","BK4536","LU1366192091.USD","LU1035773651.USD","JPM","LU0861579265.USD","IYT","LU0345769128.USD","LU2089284900.SGD","IE00BJLML261.HKD","LU0553294199.USD","LU0672654240.SGD","LU2360107325.USD","SGXZ99366536.SGD","LU1934455194.USD","SG9999015986.USD","BK4538","LU0820562030.AUD","IE00B1XK9C88.USD","LU1093756168.USD","LU0820561909.HKD","LU2430703251.USD","IE00B19Z9505.USD","BK4532","NVOC","LU1235294995.USD","LU0109391861.USD","LU0345770993.USD","LU0187121727.USD","LU1046421795.USD","LU1935042488.USD","ADBG","LU0106261372.USD","LU1935043536.SGD","LU0215105999.USD","IE000M9KFDE8.USD","SG9999003800.SGD","IE00BBT3K403.USD","IE00B1BXHZ80.USD","LU0289961442.SGD","LU1778281490.HKD","BK4581","IE0002270589.USD","LU2168564495.EUR","LU0345769631.USD","LU0552385451.USD","LU0345770308.USD","IE00BK4W5L77.USD","LU0289739343.SGD","LU2237443465.HKD","IE0034235188.USD","IE00B775SV38.USD","LU2023250330.USD","IE00B7SZLL34.SGD","LU1989764664.SGD","SG9999014906.USD","SG9999015945.SGD","LU0965509283.SGD","LU0708995401.HKD","LU1116320737.USD","IE0034235303.USD","BK4566","LU2125154935.USD","LU0889566641.SGD","LU2095319765.USD","LU2023250843.SGD","UBRL","LU1162221912.USD","IE00BWXC8680.SGD","LU1989772923.USD","IE00B19Z3581.USD","LU2242649171.HKD","LU2896262040.SGD","FNCL","SG9999002224.SGD","IE00BQXX3D17.EUR","LU0048584097.USD","LU0106831901.USD","LU2326559502.SGD","LU0957791311.USD","ORCZ","SG9999001424.SGD","LU2552382215.SGD","IE00B5TLWC47.USD","LU0738911758.USD","LU1803068979.SGD","LU2357305700.SGD","LU2264538146.SGD","BK4503","LU0320765489.SGD","LU0203347892.USD","LU0175139822.USD","LU1037948541.HKD","LU1037948897.HKD","LU1894683348.USD","LU1633808545.USD","LU0127658192.USD","BK4097","LU0157215616.USD","WNDR","LU0170899867.USD","LU2211815571.USD","LU0234570918.USD","LU2505996681.GBP","SGXZ31699556.SGD","LU2106854487.HKD","SORCLmain","LU0496365809.HKD","LU1496350171.SGD","LU2462157665.USD","LU2746668461.USD","LU1506573853.SGD","LU1814569148.SGD","LU0971096721.USD","LU0976567544.SGD","LU1316542783.SGD","BK4588","LU1267930813.SGD","OGIG","LU1935043023.USD","IE00BFXG0V08.USD","SG9999018865.SGD","LU2756315318.SGD","LU2746668974.SGD","LU0082616367.USD","LU0690374615.EUR","LU1244550221.USD","LU0210536198.USD","LU0198837287.USD","LU1989772840.SGD","BK4007","LU0208291251.USD","LU1261432733.SGD","JPMO","LU1815333072.USD","IE00BJTD4V19.USD","LU2210149790.SGD","SGXZ51526630.SGD","BK4550","BK4022","IE00BKDWB100.SGD","ORCL","LU0107464264.USD","LU1429558221.USD","LU2108987350.USD","SG9999015952.SGD","LU0234572021.USD","LU0557290698.USD","LU2236285917.USD","LU0348723411.USD","LU1069347547.HKD","TRUF","IE00BMPRXR70.SGD","LU1003077747.HKD","LU0149725797.USD","IE00BMPRXQ63.HKD","LU1861219969.SGD","IE00BLSP4452.SGD","ORCU","LU0545039389.USD","LU0433182093.SGD","BK4505","ADBE","LU2381873111.SGD","BK4543","BK4534","BK4023","IE00BJTD4N35.SGD","LU1988902786.USD","IE00BFMHRM44.USD","LU1934455277.USD","LU0289960550.SGD","LU0868494708.USD","KBWB","LU2237438978.USD","LU2360032135.SGD","LU2023251221.USD","LU1084165304.USD","IE00BDCRKT87.USD","IE00BZ199S13.USD","LU1280957306.USD","LU0057025933.USD","LU1244550494.USD","LU0787776722.HKD","LU1366333091.USD","LU0353189680.USD","LU0719512351.SGD","LU0511384066.AUD","LU0314104364.USD","LU1712237335.SGD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665109773","title":"Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2665109773","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665109773?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:10","pubTimestamp":1788804610,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination with a reduced-calo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4599","LU1093756325.SGD","NVOC","LU1093756168.USD","BK4007","NVOH","THNR","NVO","BK4532","NVOX","IE00BKVL7J92.USD","OZEM","LU0154236417.USD","IE00BZ1G4Q59.USD","PPH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665862310","title":"Novo Nordisk (NVO) Hit by Another Heart Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2665862310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665862310?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:56","pubTimestamp":1788800218,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) has halted two late‑stage studies of its experimental heart drug ziltivekimab, marking a major setback in its push into cardiov...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","NVO","BK4532","LU0154236417.USD","BK4588","LU1093756168.USD","NVOC","NVOH","THNR","BK4007","OZEM","IE00BKVL7J92.USD","NVOX","LU1093756325.SGD","PPH","BK4585","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193693103","title":"European Equities Remain Flat as Energy Gains Offset by Pharma Slump","url":"https://stock-news.laohu8.com/highlight/detail?id=1193693103","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193693103?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:30","pubTimestamp":1788798644,"startTime":"0","endTime":"0","summary":"European markets closed Monday with little movement, as rising crude prices and a sharp decline in a major pharmaceutical firm counterbalanced each other. The benchmark Stoxx Europe 600 index...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXIV","FEP","PQIN","BK4532","BKIE","APIE","OEFA","BWET","ITOL","IOCT","TIIV","TILC","IXC","WEEI","YMAR","TPIF","DRIP","IMAY","INTF","DMXF","DBC","FHIL","BUFY","AVIV","VGK","VOOV","IDUB","CWI","IFV","IE00BJT1NW94.SGD","ENHI","AVSD","MFSI","IDME","FENI","EFA","WWJD","PGRI","DMXU","IMTM","ISDX","PPIE","SPXT","ISWN","NIHI","TDI","PTEU","USE","ICOW","CVIE","OPPE","QBIF","BNO","JDVI","IEV","EPV","AIVI","JANI","GLBL","IMOM","XEML","IJAN","UPV","IE00B2B36J28.USD","KOKU","REFA","PXE","JIRE","XW","DDWM","FTXN","NVS","IQLT","EFO","IE00BJJMRZ35.SGD","BKCI","RAYD","BK4588","IQDF","TOK","GLOF","TACN","VDE","AFDM","LU0320765489.SGD","DBEF","GXUS","PIZ","BUFI","CGIE","DBE","HFXI","BK4534","DEEF","IAUG","BK4020","JPIN","GIEQ","QEFA","STXI","ILOW","VEA","FDT","IJUL","PTIN","BBIN","DBEU","EAFG","USL","HEFA","PZIV","BK4581","CEFA","PXF","XEUR","BK4570","ERX","BK4578","HAWX","EWN","VNIE","DFAI","OAIM","NUDM","UIVM","IJUN","BINV","RODE","TOUS","RODM","IVAL","PDEV","DWMF","ESIM","BK4550","JHMD","RFDI","SEIE","BK4582","EASG","XLEX","CGXU","BAIV","IDEC","DUG","IXUS","ISEP","SSXU","DFAX","FEDM","IEUR","IVSI","ICPY","EURL","FEOE","NBIE","XES","QLVD","AVDE","FFDI","UAE","DTAN","DBO","EFZ","IDMO","RINT","CGIC","EFAX","GSIE","IDMY","IGGY","RDMX","AVNM","DRLL","IDEQ","BK4167","VEFA","SPDW","DINT","IFEB","QBIV","SPEU","OILU","GSID","OILK","TPOR","DFIC","LU0208291251.USD","PPH","MOTI","WTIU","IE00B4R5TH58.HKD","BK4585","BK4504","OVF","FDEV","FLEE","BK4007","INOV","UGA","VEU","DIG","IQSI","ACWX","IE0009355771.USD","TXUE","OIH","IE00BFTCPJ56.SGD","URTH","FEZ","BRIE","MFDX","EPIN","OILT","ARLI","PIEQ","SDOG","GSEU","IEFA","JULI","EUDG","FINT","SCHF","TLTD","BBEU","WCMG","RFEU","USOI","FSZ","WCMI","YSEP","IAPR","YDEC","IFLR","IMFL","PXJ","IE0002141913.USD","IBUF","FIEE","IDEV","LU0070302665.USD","MEDX","PEJ","TLCI","VIDI","IMAR","LU0211331839.USD","IEO","IDJN","GUSH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317069","title":"Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317069?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:21","pubTimestamp":1788798066,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultrageny...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-intellia-therapeutics-ntla-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-intellia-therapeutics-ntla-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234572021.USD","LU0320765489.SGD","LU1585245621.USD","LU0211331839.USD","SG9999014567.USD","LU1941712264.USD","JDOC","IE0009355771.USD","LU1037948897.HKD","LU1066051498.USD","LU0648001328.SGD","LU1989772923.USD","LU1037948541.HKD","SG9999002232.USD","FHLC","LU1066051225.USD","IE00BBT3K403.USD","LU1035773651.USD","LU1989771016.USD","LU2324357040.USD","LU1201861249.SGD","LU1116320901.HKD","BK4535","SG9999001176.SGD","LU0058720904.USD","LU0266013472.USD","LU0477156953.USD","LU1989772840.SGD","BK4556","LU1023059063.AUD","IYH","MRK","LU0289739699.SGD","IE00BLSP4452.SGD","LU0130102774.USD","LU2491050071.SGD","LU0689626769.HKD","LU1066053197.SGD","SG9999013999.USD","LU1983299246.USD","PPH","LU1032466523.USD","LU2125154935.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU0432979614.USD","LU0203347892.USD","LU0265550946.USD","LU0098860793.USD","LU1291159041.SGD","LU0320765646.SGD","LU1974910355.USD","LU2491050154.USD","LU2125154778.USD","IE00B4R5TH58.HKD","LU1934455194.USD","LU0203345920.USD","LU2361044949.HKD","LU2468319806.SGD","LU0965509283.SGD","LU2106854487.HKD","LU2361045086.USD","LU1699723380.USD","LU0265550359.USD","VHT","SG9999014559.SGD","LU0859254822.USD","LU1861558580.USD","LU0965508806.USD","LU1923622614.USD","LU2360032135.SGD","LU2023250504.SGD","SG9999014575.USD","SG9999014542.SGD","LU0124676726.USD","LU1069347547.HKD","LU1934455277.USD","LU0106261372.USD","SG9999002224.SGD","LU2125909593.SGD","IXJ","LU1430594728.SGD","LU1093756325.SGD","LU0965509010.AUD","RXL","LU1861559042.SGD","SGXZ57979304.SGD","SG9999015358.SGD","SG9999001176.USD","IE00B2B36J28.USD","LU2491049909.HKD","LU0861579265.USD","BK4585","LU2125909247.SGD","LU1934455863.HKD","IE00BSNM7G36.USD","IHE","BK4139","LU0868494617.USD","LU1057294990.SGD","IE00BLSP4239.USD","IE0002141913.USD","BK4007","IE00BN8TJ469.HKD","NTLA","RARE","LU2357627491.SGD","FTXH","IE000M9KFDE8.USD","LU1929549753.HKD","LU2433249047.HKD","LU0130517989.USD","BK4559","BK4516","TRUH","LU0070302665.USD","LU2112291526.USD","SG9999001440.SGD","BMED","LU2461242641.AUD","PAWZ","LU1066051811.HKD","LU1571399168.USD","LU2023250843.SGD","LU0942090050.USD","SG9999015341.SGD","GDOC","LU0238689110.USD","LU1061106388.HKD","LU0122379950.USD","LU0208291251.USD","LU1917777945.USD","LU0868494708.USD","LU2361044865.SGD","IE00BJT1NW94.SGD","BK4588","LU0985320562.USD","IE00B1BXHZ80.USD","BK4534","LU1116320737.USD","BK4550","LU0823416689.USD","LU0006306889.USD","LU0965509101.SGD","LU1941712348.USD","LU1162221912.USD","BK4533","HRTS","LU1093756168.USD","IE00BFTCPJ56.SGD","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317208","title":"Novartis AG Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317208","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317208?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:15","pubTimestamp":1788797700,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  dropped 3.2% to CHF125.46 Monday on what proved to be an overall unfavorable trading session for the stock market, with the Swiss Market Index SMI Index  falling 0.8% to 14,279.38.Novartis AG closed CHF7.22 short of its 52-week high of CHF132.68, which the company achieved on September 3, 2026.Trading volume was 3,077,526, compared to the 50-day average trading volume of 2,290,037.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","IE0002141913.USD","IE00B4R5TH58.HKD","BK4007","LU0208291251.USD","IE00B2B36J28.USD","MEDX","LU0211331839.USD","NVS","BK4585","PPH","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK4532","BK4578","IE0009355771.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731749","title":"Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731749?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:02","pubTimestamp":1788796920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B were flat  at DKK298.95 Monday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.3% to 2,710.84.The stock's rise  snapped a two-day losing streak.The company closed DKK111.00 short of its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 1,797,150, compared to the 50-day average trading volume of 4,122,224.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","BK4585","IE00BZ1G4Q59.USD","NVO","BK4588","IE00BKVL7J92.USD","LU1093756168.USD","PPH","BK4007","NVOC","NVOH","NVOX","OZEM","THNR","LU1093756325.SGD","BK4599","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665176793","title":"Citi says Novartis news increases likelihood Crispr prioritizes next-gen CTX321","url":"https://stock-news.laohu8.com/highlight/detail?id=2665176793","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665176793?lang=en_us&edition=fundamental","pubTime":"2026-09-07 23:20","pubTimestamp":1788794419,"startTime":"0","endTime":"0","summary":"After Novartis (NVS) reported that pelacarsen’s Phase 3 HORIZON study failed to demonstrate a statistically significant reduction in major adverse ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-says-novartis-news-increases-likelihood-crispr-prioritizes-next-gen-ctx321-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-says-novartis-news-increases-likelihood-crispr-prioritizes-next-gen-ctx321-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765489.SGD","BK4585","BK4007","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","MEDX","BK4532","LU0208291251.USD","LU0070302665.USD","BK4588","IE00BJT1NW94.SGD","PPH","BK4578","LU0211331839.USD","NVS","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665552317","title":"Citi sees limited immediate downside for Ionis after pelacarsen failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2665552317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665552317?lang=en_us&edition=fundamental","pubTime":"2026-09-07 23:15","pubTimestamp":1788794109,"startTime":"0","endTime":"0","summary":"After Ionis’ (IONS) partner Novartis (NVS) disclosed that the pelacarsen Phase 3 Lp(a)HORIZON study failed to meet its primary endpoint of cardiova...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-sees-limited-immediate-downside-for-ionis-after-pelacarsen-failure-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-sees-limited-immediate-downside-for-ionis-after-pelacarsen-failure-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","LU0211331839.USD","BK4139","PPH","MEDX","BK4585","BK4578","BK4588","LU0070302665.USD","IONS","NVS","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4532","IE0002141913.USD","BK4007","LU0320765489.SGD","LU0208291251.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131175","title":"Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131175?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:32","pubTimestamp":1788784376,"startTime":"0","endTime":"0","summary":"Novo Nordisk’s ($NVO) shares in Copenhagen edged lower on Monday afternoon. This came even after the Danish pharma giant said in a statement that i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4532","NVOH","PPH","LU1093756325.SGD","LU0154236417.USD","BK4599","LU1093756168.USD","NVOC","THNR","OZEM","BK4585","BK4007","NVO","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311682","title":"BofA sees low single-digit percentage downside for Novartis on pelacarsen miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311682","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311682?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:00","pubTimestamp":1788782433,"startTime":"0","endTime":"0","summary":"After Novartis (NVS) announced pelacarsen missed its primary endpoint of reducing cardiovascular events in the Phase 3 HORIZON study, BofA sees low...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bofa-sees-low-single-digit-percentage-downside-for-novartis-on-pelacarsen-miss-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bofa-sees-low-single-digit-percentage-downside-for-novartis-on-pelacarsen-miss-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MEDX","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4588","IE00B2B36J28.USD","PPH","LU0320765489.SGD","BK4578","BK4585","IE0009355771.USD","IE0002141913.USD","NVS","IE00BJT1NW94.SGD","LU0211331839.USD","LU0070302665.USD","BK4532","LU0208291251.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665023390","title":"ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2665023390","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665023390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:35","pubTimestamp":1788770131,"startTime":"0","endTime":"0","summary":"ASB Ventures-backed Boundary Zhikong’s Navista eVTOL navigation system enters CAAC airworthiness reviewShenzhen ASB Ventures portfolio company Boundary Intelligent Control secured CAAC acceptance of a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL7rkwzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491050071.SGD","LU2237443895.HKD","BK4516","SG9999014906.USD","BK4211","LU0708995401.HKD","LU0820561909.HKD","XLV","LU1291159041.SGD","LU0256863811.USD","LU0006306889.USD","LU0943347566.SGD","LU1323610961.USD","LU2089284900.SGD","LU2237443465.HKD","LU0353189680.USD","LU1093756168.USD","LU2168564065.EUR","MEDX","BK4007","LLII","LU2237443978.SGD","LU0225283273.USD","LU1548497426.USD","LU2023250504.SGD","LU2168564149.EUR","LU1979441026.SGD","LU0786609619.USD","LU2023251221.USD","LU2211815571.USD","LU0158827948.USD","LU2168564495.EUR","LU2471134952.CNY","LU1061106388.HKD","LU1868837136.USD","SGXZ31699556.SGD","BK4585","IHE","LU2602419157.SGD","LU2108987350.USD","THNR","LU2491050154.USD","LU2237443549.SGD","LU0203201768.USD","IE00BJLML261.HKD","LU2213496289.HKD","LU1814569148.SGD","LU0109394709.USD","LU1974910355.USD","LU1983299246.USD","SG9999015945.SGD","LU1629891620.HKD","LU0882574139.USD","LU2106854487.HKD","LU0345770308.USD","MHIP","LU0823434740.USD","IE0002141913.USD","CURE","LU2028103732.USD","LU0320765059.SGD","LU2111349929.HKD","LU0964807845.USD","LU2089283258.USD","LU2324357040.USD","LU0114720955.EUR","MEDI","LU1988902786.USD","LU2237443622.USD","LU2271345857.HKD","SG9999001176.USD","CANC","LU0079474960.USD","LU1145028129.USD","IE00BJJMRY28.SGD","LU2089984988.USD","LU1712237335.SGD","LU0289739699.SGD","LU2112291526.USD","LU0109391861.USD","SGXZ57979304.SGD","SG9999014880.SGD","SG9999014914.USD","LU2468319806.SGD","LU2552382058.USD","LU2357305700.SGD","SG9999017495.SGD","IE0004445239.USD","LU1720051017.SGD","LU0640476718.USD","GB00BDT5M118.USD","ELIL","IE00BWXC8680.SGD","LU1989771016.USD","LU2361044865.SGD","BK4599","LU1868836591.USD","IE0009355771.USD","LU1691799644.USD","TMED","LU0471298777.SGD","LU1127390331.HKD","LU0323591593.USD","LLYZ","LU2417539215.USD","IE00BKDWB100.SGD","LU0385154629.USD","LLYX","RXL","LU2360106947.USD","SG9999013999.USD","BK4534","LU2462591350.SGD","LU2756315664.SGD","ILDR","IE00B2B36J28.USD","LU1551013425.SGD","LU2087625088.SGD","VHT","LU2471134523.USD","LU0133085943.USD","LU2746668974.SGD","OZEM","JDOC","IE00BKPKM429.USD","LU2456880835.USD","LU0106261372.USD","LLY","LU2237443382.USD","LU1551013342.USD","IE00B4JS1V06.HKD","LU0256863902.USD","LU0354030511.USD","LU1804176565.USD","IE0005OL40V9.USD","LU1868836914.USD","LU0823434583.USD","LU2552382132.HKD","TRUH","HRTS","LU2361044949.HKD","GDOC","SG9999015986.USD","LU2361045086.USD","LU0097036916.USD","LU0238689110.USD","IE00B1BXHZ80.USD","LU2491049909.HKD","LU0320765992.SGD","LU0683600562.USD","SG9999014898.SGD","IE00B7KXQ091.USD","LU1232071149.USD","SG9999001176.SGD","LU0122379950.USD","LU0820561818.USD","LU0266013472.USD","LU0058720904.USD","LU1035775433.USD","BK4581","BK4533","LU1069344957.HKD","LU1720051108.HKD","LU2750360997.AUD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0158827781.USD","LU0471298694.HKD","LU2265009873.SGD","IE00B1XK9C88.USD","IE00BFSS8Q28.SGD","LU0198837287.USD","IE00BJJMRX11.SGD","LU0203202063.USD","LU0316494557.USD","LU0456855351.SGD","AGNG","BK4588","LU0823416689.USD","LU1267930730.SGD","LU2461242641.AUD","LU2471134879.HKD","LU2237438978.USD","LU0432979614.USD","IE00BJT1NW94.SGD","LU0096364046.USD","LU2168563687.JPY","LU0417517546.SGD","LU1868836757.USD","LU1917777945.USD","LU2471134796.USD","PJP","SG9999015978.USD","LU1623119135.USD","LU2746668461.USD","FHLC","SGXZ51526630.SGD","LU0689472784.USD","IE0004445015.USD","LU2462157665.USD","SG9999018865.SGD","LU0353189763.USD","LU2750360641.GBP","IYH","SG9999018857.SGD","LU2063271972.USD","LU2023250330.USD","LU0672654240.SGD","LU2756315318.SGD","LU0234572021.USD","LU1064131342.USD","IE00BJJMRZ35.SGD","IXJ","LU0787776722.HKD","LU0466842654.USD","LU2236285917.USD","LU1023059063.AUD","SGXZ81514606.USD","LU0882574055.USD","ELIS","LU0210536198.USD","FTXH","IE00BK4W5M84.HKD","LU0345770993.USD","ASB","LU0094547139.USD","LU0889565916.HKD","LU1280957306.USD","PPH","WDNA","IE0001KFT4U8.USD","LU1093756325.SGD","LU0820562030.AUD","LU1868837300.USD","IE00BK4W5L77.USD","LU0061475181.USD","LU1057294990.SGD","LU2168564222.USD","LU2552382215.SGD","SGXZ99366536.SGD","LU0174119429.USD","LU0354030438.USD","IE00BFSS7M15.SGD","LU2264538146.SGD","LU2896262040.SGD","IE00BN29S564.USD","IE00B775H168.HKD","SG9999015952.SGD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390614","title":"Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390614","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390614?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768672,"startTime":"0","endTime":"0","summary":"UPDATE 2-Novartis cholesterol setback tests hopes for emerging heart disease drugsLONDON, Sept 7 (Reuters)-Shares of NovartisNOVN.Sfell more than 3% on Monday after its cholesterol drug failed in a cl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL1N44Z05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0097036916.USD","MEDX","LU2361044865.SGD","THNR","LLY","AGNG","IBB","WDNA","LLII","IXJ","LU1691799644.USD","FHLC","MHIP","LU1267930730.SGD","SGXZ99366536.SGD","IBBQ","LU0823434583.USD","ELIL","IYH","LLYZ","BIB","LU1571399168.USD","OZEM","PPH","RXL","VHT","PBE","ELIS","LU2750360641.GBP","AMGN","IHE","NAMS","TBXU","BBH","FTXH","LLYX","MEDI","CURE","CANC","HRTS","GDOC","XLV","TMED","TRUH","LU2089284900.SGD","PJP","JDOC","IE00BJJMRY28.SGD","SLN","ILDR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665572390","title":"Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665572390","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665572390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:03","pubTimestamp":1788768180,"startTime":"0","endTime":"0","summary":"Novartis shares fell after the Swiss drugmaker said an experimental medicine failed to reduce cardiovascular risk in a late-stage clinical trial.Shares in Novartis were down 3.2% in European morning t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BFTCPJ56.SGD","LU0320765489.SGD","NVS","LU0208291251.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B2B36J28.USD","MEDX","LU0070302665.USD","BK4532","IE00BJT1NW94.SGD","BK4585","BK4588","LU0211331839.USD","IE0009355771.USD","BK4578","PPH","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397422","title":"Novartis India to Acquire 'Minipress' Trademarks from Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397422","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397422?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:43","pubTimestamp":1788767020,"startTime":"0","endTime":"0","summary":"BRIEF-Novartis India To Acquire 'Minipress' Trademarks From PfizerSept 7 (Reuters)-Novartis India LtdNOIN.BO:TO ACQUIRE 'MINIPRESS' TRADEMARKS FROM PFIZERSource text:ID:nBSE74jJ9yFurther company coverage:NOIN.BO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44Y00E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU0321505868.SGD","LU0321505439.SGD","IE00BJT1NW94.SGD","IE0002270589.USD","IE00BJJMRZ35.SGD","LU0306807586.USD","LU0456855351.SGD","BK4534","IE0002141913.USD","IE00BBT3K403.USD","MEDX","BK4007","PPH","SG9999003800.SGD","BK4532","LU0289739699.SGD","IE00B19Z3B42.SGD","BK4592","LU0225284248.USD","SG9999001176.USD","LU0320765489.SGD","LU1023059063.AUD","LU0058720904.USD","LU1894683264.USD","BK4578","BK4585","IE00B3T34201.USD","SG9999001176.SGD","NVS","LU1066051498.USD","LU1894683348.USD","PFE","SG9999002232.USD","IE0009355771.USD","IE000M9KFDE8.USD","LU0234572021.USD","SG9999011175.SGD","SGXZ57979304.SGD","BK4550","LU0170899867.USD","IE00B19Z3581.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0208291251.USD","LU1066053197.SGD","LU2596442595.SGD","LU0985481810.HKD","IE00BLSP4239.USD","OZEM","LU0868494617.USD","IE00BLSP4452.SGD","BK4568","LU0225771236.USD","SG9999013999.USD","LU0122379950.USD","LU0306806265.USD","BK4588","BK4581","BK4533","LU0211331839.USD","IE00BFTCPJ56.SGD","LU1883839398.USD","LU0070302665.USD","SG9999002224.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104786890","title":"Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1104786890","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104786890?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:22","pubTimestamp":1788765738,"startTime":"0","endTime":"0","summary":"Swiss pharma giant Novartis AG (NVS.US) has suffered another clinical trial setback, marking the second high-profile candidate to fail in late-stage studies within a single week. The latest casualty...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","IBB","PBE","LU0320765992.SGD","LU0109394709.USD","BK4566","PPH","BK4585","BIB","LU1057294990.SGD","IBBQ","IE00BJT1NW94.SGD","BK4599","LU0868494617.USD","TBXU","AMGN","LU0889565916.HKD","SG9999001440.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","NVS","BK4007","IE00BFTCPJ56.SGD","LU0208291251.USD","LU1061106388.HKD","LU2112291526.USD","BK4578","LU0122379950.USD","LU1571399168.USD","IE0009355771.USD","LU0320765489.SGD","IE00B2B36J28.USD","LU2242646821.SGD","BK4139","LU0070302665.USD","BK4534","IE00B4R5TH58.HKD","BK4533","BBH","BK4581","LU0211331839.USD","MEDX","LU1023059063.AUD","LU0289739699.SGD","LU1983299246.USD","LU2089984988.USD","BK4532","BK4588","PJP","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392965","title":"Novartis Heart-Trial Failure Could be Mitigated by Investor Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392965","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392965?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:04","pubTimestamp":1788764640,"startTime":"0","endTime":"0","summary":"0703 GMT - An experimental Novartis medicine missed the target in a late-stage clinical trial, but the hit to the Swiss drugmaker's share price could be mitigated by investors' skepticism about the study, analysts at Citi say in a research note. The drug, pelacarsen, reduced the levels of a fatty particle in the blood known as Lp, but this didn't translate to clinical outcomes, Citi says. \"We think market expectations of a positive trial were already cautious, with question marks around the magnitude of benefit and difficulty in commercialization even if the study had met the endpoint, which we think could limit the impact of the trial failure on the share price,\" the analysts say.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","LU0320765489.SGD","LU0211331839.USD","IE0009355771.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","NVS","LU0208291251.USD","BK4585","BK4532","IE00BJT1NW94.SGD","BK4588","PPH","IE0002141913.USD","BK4007","BK4578","IE00BJJMRZ35.SGD","MEDX","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665391143","title":"Novartis India - Deal Valued at 12.50 Bln Rupees","url":"https://stock-news.laohu8.com/highlight/detail?id=2665391143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665391143?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:56","pubTimestamp":1788760577,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44Y00E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","BK4007","MEDX","LU0070302665.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","LU0211331839.USD","BK4532","BK4585","LU0320765489.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4578","BK4588","NVS","PPH","IE00BJT1NW94.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665684391","title":"Novartis Shares to Take Hit from Cholesterol Trial Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2665684391","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665684391?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:43","pubTimestamp":1788759780,"startTime":"0","endTime":"0","summary":"0543 GMT - Novartis shares are likely to take a hit from news that a cholesterol drug candidate failed to reduce the risk of severe cardiovascular events like heart attacks and strokes in a late-stage trial, J.P. Morgan analysts say in a research note. Consensus estimates for Novartis included $1 billion in 2030 sales from the drug, called pelacarsen, the analysts say. Shares in the Swiss drugmaker are likely to be off 2% to 3% on Monday as a result, they add. Upcoming trial results for del-desiran, an experimental treatment for genetic neuromuscular disorder myotonic dystrophy type 1, are likely to be positive and could allow Novartis to more than erase stock weakness caused by the pelacarsen results, according to JPM.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Novartis Shares to Take Hit from Cholesterol Trial Failure","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0009355771.USD","NVS","LU0320765489.SGD","BK4585","IE00BJT1NW94.SGD","BK4007","LU0211331839.USD","LU0208291251.USD","BK4588","BK4532","PPH","BK4578","IE0002141913.USD","LU0070302665.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":9,"totalSize":242,"code":"91000000","status":"200"}]}}